Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

AdaptHealth (AHCO) Capital Expenditures (2019 - 2026)

AdaptHealth has reported Capital Expenditures over the past 7 years, most recently at $321.0 million for Q4 2025.

For Q4 2025, Capital Expenditures rose 23.76% year-over-year to $321.0 million; the TTM value through Dec 2025 reached $382.4 million, up 24.94%, while the annual FY2025 figure was $382.4 million, 24.94% up from the prior year.
Capital Expenditures for Q4 2025 was $321.0 million at AdaptHealth, up from $2.3 million in the prior quarter.
Over five years, Capital Expenditures peaked at $321.0 million in Q4 2025 and troughed at -$139.2 million in Q3 2023.
A 5-year average of $81.0 million and a median of $60.9 million in 2021 define the central range for Capital Expenditures.
Biggest five-year swings in Capital Expenditures: soared 13920.35% in 2022 and later plummeted 247.87% in 2023.
Year by year, Capital Expenditures stood at $63.6 million in 2021, then surged by 124.63% to $142.9 million in 2022, then soared by 113.41% to $305.0 million in 2023, then fell by 14.97% to $259.3 million in 2024, then increased by 23.76% to $321.0 million in 2025.
Business Quant data shows Capital Expenditures for AHCO at $321.0 million in Q4 2025, $2.3 million in Q3 2025, and $920000.0 in Q2 2025.